-
公开(公告)号:EP3928788A1
公开(公告)日:2021-12-29
申请号:EP21173790.3
申请日:2015-11-25
申请人: Xencor, Inc.
发明人: MOORE, Gregory , DESJARLAIS, John , BERNETT, Matthew , CHU, Seung , RASHID, Rumana , MUCHHAL, Umesh , LEE, Sung-Hyung
摘要: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:EP3237449A2
公开(公告)日:2017-11-01
申请号:EP15825645.3
申请日:2015-12-22
申请人: Xencor, Inc.
发明人: MOORE, Gregory , DESJARLAIS, John , CHU, Seung , LEE, Sung-Hyung
IPC分类号: C07K16/28
CPC分类号: C07K16/2887 , C07K16/2803 , C07K16/2809 , C07K16/2815 , C07K16/2866 , C07K16/2896 , C07K2317/31 , C07K2317/52 , C07K2317/60 , C07K2317/622 , C07K2317/626
摘要: The invention provides trispecific antibodies that co-engage CD3, CD8 and a tumor target antigen.
摘要翻译: 本发明提供了共同结合CD3,CD8和肿瘤靶抗原的三特异性抗体。
-
公开(公告)号:EP3930850A1
公开(公告)日:2022-01-05
申请号:EP20715585.4
申请日:2020-02-28
申请人: Xencor, Inc.
-
公开(公告)号:EP3475304A1
公开(公告)日:2019-05-01
申请号:EP17740525.5
申请日:2017-06-28
申请人: Xencor, Inc.
发明人: MOORE, Gregory , RASHID, Rumana , LEE, Sung-Hyung , FOSTER, Paul
-
公开(公告)号:EP4305067A1
公开(公告)日:2024-01-17
申请号:EP22716136.1
申请日:2022-03-09
申请人: Xencor, Inc.
-
公开(公告)号:EP4059514A1
公开(公告)日:2022-09-21
申请号:EP22155270.6
申请日:2016-04-28
申请人: Xencor, Inc.
发明人: MOORE, Gregory , DESLARLAIS, John , BERNETT, Matthew , CHU, Seung , RASHID, Rumana , MUCHHAL, Umesh , LEE, Sung-Hyung
摘要: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:EP4050032A1
公开(公告)日:2022-08-31
申请号:EP22156183.0
申请日:2017-06-28
申请人: Xencor, Inc.
发明人: MOORE, Gregory , RASHID, Rumana , LEE, Sung-Hyung , FOSTER, Paul
摘要: The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind somatostatin receptor 2 (SSTR2).
-
公开(公告)号:EP3236996A1
公开(公告)日:2017-11-01
申请号:EP16721604.3
申请日:2016-04-28
申请人: Xencor, Inc.
发明人: MOORE, Gregory , DESLARLAIS, John , BERNETT, Matthew , CHU, Seung , RASHID, Rumana , MUCHHAL, Umesh , LEE, Sung-Hyung
CPC分类号: C07K16/2809 , A61K2039/505 , C07K16/2896 , C07K16/30 , C07K16/468 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/60 , C07K2317/622 , C07K2317/73 , C07K2317/92
摘要: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:EP3223845A2
公开(公告)日:2017-10-04
申请号:EP15805722.4
申请日:2015-11-25
申请人: Xencor, Inc.
发明人: MOORE, Gregory , DESJARLAIS, John , BERNETT, Matthew , CHU, Seung , RASHID, Rumana , MUCHHAL, Umesh , LEE, Sung-Hyung
CPC分类号: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2818 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention is directed to novel heterodimeric antibodies.
摘要翻译: 本发明涉及新的异二聚体抗体。
-
-
-
-
-
-
-
-